Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT: NCT06553625 · RECRUITING

NCT IDNCT06553625
StatusRECRUITING
Start Date2024-01-29
Completion2035-12

Brief Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Frequently Asked Questions

What is Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS?

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS is a clinical trial registered under NCT06553625. Current status: RECRUITING.

What is the status of NCT06553625?

The current status of NCT06553625 (Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS) is: RECRUITING.

When did Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS start?

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS started on 2024-01-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑